Merck, Starpharma expand partnership to develop antibody drug conjugates
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
Urged stakeholders to come up with similar digital platforms and create homegrown best practices where Indian methods and Indian solutions dominate the digital spaces
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
Lupin is the 6th largest company in the Indian Pharmaceutical Market
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Subscribe To Our Newsletter & Stay Updated